| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | KRG | United States | $24.49 | $844,365,000.00 | Buy | 11 | 2004 |
#2 | CDE | United States | $18.34 | $709,598,000.00 | Strong Buy | 5 | 1994 |
#3 | CSTM | France | $24.77 | $8,449,000,000.00 | Strong Buy | 4 | 2012 |
#4 | FIVN | United States | $15.08 | $1,149,088,000.00 | Buy | 19 | 2014 |
#5 | VRRM | United States | $14.24 | $132,969,000.00 | Buy | 5 | 2016 |
#6 | TBPH | United States | $14.88 | $15,386,000.00 | Strong Buy | 5 | 2013 |
#7 | KNSA | United Kingdom | $44.98 | $677,564,000.00 | Strong Buy | 7 | 2018 |
#8 | PACS | United States | $33.81 | $5,288,932,000.00 | Strong Buy | 4 | 2024 |
#9 | LEVI | United States | $18.49 | $6,282,000,000.00 | Strong Buy | 13 | 2019 |
#10 | AORT | United States | $35.62 | $298,836,000.00 | Strong Buy | 5 | 1996 |
#11 | AMRX | United States | $12.07 | $0.00 | Strong Buy | 4 | 2018 |
#12 | NTST | United States | $18.96 | $195,006,000.00 | Strong Buy | 13 | 2020 |
#13 | KROS | United States | $11.00 | $243,864,000.00 | Buy | 8 | 2020 |
#14 | RUN | United States | $12.84 | $858,578,000.00 | Buy | 20 | 2015 |
#15 | APLS | United States | $17.28 | $1,003,782,000.00 | Buy | 21 | 2015 |
#16 | AFRM | United States | $44.86 | $3,224,412,000.00 | Buy | 29 | 2020 |
#17 | SLNO | United States | $31.38 | $1,450,788.00 | Strong Buy | 11 | 2014 |
#18 | WGO | United States | $35.06 | $1,985,674,000.00 | Buy | 11 | 1994 |
#19 | WBD | United States | $27.28 | $0.00 | Buy | 20 | 2008 |
#20 | ABM | United States | $37.96 | $8,745,900,000.00 | Buy | 5 | 1994 |
#21 | ALHC | United States | $17.41 | $3,948,719,000.00 | Buy | 10 | 2021 |
#22 | CTRE | United States | $37.16 | $476,393,000.00 | Buy | 9 | 2013 |
#23 | MEG | United States | $22.58 | $830,538,000.00 | Buy | 4 | 2020 |
#24 | STOK | United States | $32.06 | $184,420,000.00 | Strong Buy | 10 | 2019 |
#25 | ARQT | United States | $21.85 | $376,072,000.00 | Strong Buy | 6 | 2020 |
#26 | BEAM | United States | $23.97 | $24,000.00 | Buy | 13 | 2019 |
#27 | PECO | United States | $36.80 | $726,594,000.00 | Buy | 8 | 2010 |
#28 | BILL | United States | $38.54 | $1,462,570,000.00 | Buy | 22 | 2019 |
#29 | AVTX | United States | $13.44 | $27,813,137.00 | Strong Buy | 8 | 2015 |
#30 | ACAD | United States | $20.95 | $726,437,000.00 | Buy | 22 | 2000 |
#31 | SHC | United States | $13.85 | $1,163,617,000.00 | Buy | 7 | 2020 |
#32 | AMLX | United States | $13.65 | $380,786,000.00 | Strong Buy | 9 | 2021 |
#33 | ADPT | United States | $13.91 | $276,976,000.00 | Strong Buy | 9 | 2019 |
#34 | IDYA | United States | $30.66 | $218,710,000.00 | Strong Buy | 16 | 2019 |
#35 | AZTA | United States | $21.28 | $593,821,000.00 | Strong Buy | 5 | 1996 |
#36 | ARVN | United States | $10.28 | $262,600,000.00 | Buy | 20 | 2018 |
#37 | SGRY | United States | $12.03 | $1,145,438,000.00 | Buy | 8 | 2015 |
#38 | HCSG | United States | $19.36 | $1,837,173,000.00 | Buy | 6 | 1994 |
#39 | IMNM | United States | $20.30 | $6,941,000.00 | Strong Buy | 10 | 2020 |
#40 | CRVS | United States | $13.15 | $0.00 | Strong Buy | 5 | 2016 |
#41 | KDP | United States | $26.17 | $16,603,000,000.00 | Buy | 17 | 2007 |
#42 | U | United States | $18.10 | $1,849,648,000.00 | Buy | 22 | 2020 |
#43 | PHAT | United States | $10.10 | $175,110,000.00 | Strong Buy | 6 | 2019 |
#44 | IRT | United States | $15.12 | $657,696,000.00 | Buy | 10 | 2009 |
#45 | MLYS | United States | $22.85 | $0.00 | Strong Buy | 6 | 2023 |
#46 | MVBF | United States | $25.36 | $3,400,000.00 | Strong Buy | 5 | 2004 |
#47 | FIBK | United States | $33.33 | $0.00 | Buy | 7 | 1997 |
#48 | KOD | United States | $21.98 | $0.00 | Buy | 7 | 2018 |
#49 | SBH | United States | $13.86 | $3,701,424,000.00 | Buy | 6 | 2006 |
#50 | LOB | United States | $32.73 | $0.00 | Buy | 4 | 2014 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $50 to Buy (March 24, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.